Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation - A transesophageal echocardiographic study

Japanese Circulation Journal

Volumn 65, Issue 4, 2001, Pages 271-274

  Kimura, M ^a   Wasaki, Y ^a   Ogawa, H ^a   Nakatsuka, M ^a   Wakeyama, T ^a   Iwami, T ^a   Ono, K ^a   Nakao, F ^a   Matsuzaki, M ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Left atrial thrombus; Low intensity warfarin therapy; Transesophageal echocardiography

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DIABETES COMPLICATIONS; DRUG EVALUATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; HYPERTENSION; HYPERTHYROIDISM; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THROMBOSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; WARFARIN;

EID: 0035045867     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.271     Document Type: Article

References (25)

1. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
2. Correlation of arrhythmias and conduction defects on the resting electrocardiogram with new cardiac events in 1153 elderly patients
3. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study
4. Atrial fibrillation and stroke: New ideas, persisting dilemmas
5. Inference of etiology of atrial fibrillation on incidence of systemic embolism
6. Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk
7. Predictors of thromboembolism in atrial fibrillation. II. Echocardiographic features of patients at risk
8. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus
9. Atrial septal aneurysm and stroke: A transesophageal echocardiographic study
10. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events
11. Prevalence and clinical implications of atrial spontaneous echo contrast in patients undergoing transesophageal echocardiography
12. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation
13. Clinical implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation
14. Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation
15. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis
16. Ultrasonography of blood during stasis and coagulation
17. Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk
18. Left atrial thrombus in non-rheumatic atrial fibrillation: Assessment of prevalence by transesophageal echocardiography
19. Embolism in left atrial/appendage thrombi (ELAT)
20. Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final result of a prospective 4.5-year study
21. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
22. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy
23. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation
24. Antithrombotic treatment and atrial fibrillation
25. Adjusted-dose warfarin therapy versus low-intensity, fixed-dose warfarin therapy plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial